Literature DB >> 727764

Effect of antibiotics on the prevention of experimental Bacteroides fragilis endocarditis.

P L Goldman, D T Durack, R G Petersdorf.   

Abstract

The relative efficacy of single doses of antibiotics in modifying the development of Bacteroides fragilis subsp. fragilis endocarditis was studied in an experimental model. Antibiotics were administered 0.5 h before intravenous injection of B. fragilis subsp. fragilis into rabbits prepared by insertion of a polyethylene catheter into the left side of the heart; 48 h later, intracardiac vegetations were excised and cultured anaerobically. B. fragilis was recovered from 92% of untreated animals. After a single dose of procaine penicillin G (250 mg/kg intramuscularly), 80% of the animals remained infected. Chloramphenicol (30 mg/kg), carbenicillin (50 mg/kg), and metronidazole (10 mg/kg) were also ineffective (76, 80, and 75% infected, respectively). Cefamandole (30 mg/kg), cefoxitin (30 mg/kg), and erythromycin (30 mg/kg) were significantly more active (50, 55, and 45% infected, respectively), as were higher doses of carbenicillin. Clindamycin (50 mg/kg) was the most effective regimen (11% infected). At present, the relevance of these results to the therapy of serious B. fragilis infections is not known, but this model may prove useful in the evaluation of the prevention of B. fragilis subsp. fragilis bacteremia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 727764      PMCID: PMC352546          DOI: 10.1128/AAC.14.5.755

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Treatment of bacterial endocarditis.

Authors:  M FINLAND
Journal:  N Engl J Med       Date:  1954-03-04       Impact factor: 91.245

2.  Effect of warfarin on the induction and course of experimental Staphylococcus epidermidis endocarditis.

Authors:  L Thörig; J Thompson; F Eulderink
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

3.  Synergistic action of erythromycin and cefamandole against Bacteroides fragilis subsp. fragilis.

Authors:  R S Griffith; G L Brier; J D Wolny
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

4.  Experimental Bacteroides fragilis endocarditis in rabbits.

Authors:  J Carrizosa; D Tanphaichitra; M E Levison
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

5.  Clinical pharmacology of carbenicillin compared with other penicillins.

Authors:  H C Standiford; M C Jordan; W M Kirby
Journal:  J Infect Dis       Date:  1970-09       Impact factor: 5.226

6.  Chemotherapy of an experimental Bacteroides fragilis infection in mice.

Authors:  C B Walker; D Nitzan; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

7.  Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis.

Authors:  D T Durack; M K Starkebaum; R G Petersdorf
Journal:  J Lab Clin Med       Date:  1977-07

8.  Protective role of complement in experimental Escherichia coli endocarditis.

Authors:  D T Durack; P B Beeson
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

9.  Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations.

Authors:  L S Young; W J Martin; R D Meyer; R J Weinstein; E T Anderson
Journal:  Ann Intern Med       Date:  1977-04       Impact factor: 25.391

10.  In vitro activity and clinical efficacy of clindamycin in the treatment of infections due to anaerobic bacteria.

Authors:  M E Levison; J Santoro; J L Bran; K Ries; W Rubin
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

View more
  2 in total

1.  Myocardial abscess with complete heart block complicating anaerobic infective endocarditis.

Authors:  H A Kopelman; B S Graham; M B Forman
Journal:  Br Heart J       Date:  1986-07

2.  Anaerobic orbital cellulitis: a clinical and experimental study.

Authors:  M S Jedrzynski; J D Bullock; T W McGuire; B L Elder; J D Bullock
Journal:  Trans Am Ophthalmol Soc       Date:  1991
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.